Governance, management and clinical risk
Graeme T. Houghton
+ Author Affiliations
- Author Affiliations
School of Public Health, La Trobe University, VIC 3068, Australia. Email: gthoughton@gmail.com
Australian Health Review 36(3) 282-283 https://doi.org/10.1071/AH11065
Submitted: 6 July 2011 Accepted: 22 December 2011 Published: 16 July 2012
References
[1] Scally G, Donaldson L. Clinical governance and the drive for quality improvement in the new NHS in England. BMJ 1998; 317 61-65| Clinical governance and the drive for quality improvement in the new NHS in England.Crossref | GoogleScholarGoogle Scholar | 9651278PubMed |
[2] Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The quality in Australian health care study. Med J Aust 1995; 163 458–71.
| 1:STN:280:DyaK28%2FosV2qsQ%3D%3D&md5=e676eca63292f5ebf3d048b7d8e42abaCAS | 7476634PubMed |
[3] Victorian Quality Council. The Healthcare Board’s role in clinical governance. Melbourne: Metropolitan Health and Aged Care Services Division. Melbourne: Department of Human Services; 2004. Available at http://www.health.vic.gov.au/qualitycouncil/downloads/clingov_hboard.pdf, [verified 30 November 2011].
[4] Griffin FA, Resar RK. IHI global trigger tool for measuring adverse events. IHI Innovation Series white paper. Cambridge, MA: Institute for Healthcare Improvement; 2011. Available at http://www.ihi.org/knowledge/Pages/Tools/IHIGlobalTriggerToolforMeasuringAEs.aspx [verified 30 November 2011].
